Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Shibata

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Cancer Research|July 11, 2021
Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung CancerYukie Kashima, Daisuke Shibahara, Ayako Suzuki, et al.
Scientific Reports|April 14, 2017
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatientsKen Tashiro, Nobuyuki Horita, Kenjiro Nagai, et al.
Internal Medicine (Tokyo, Japan)|January 12, 2018
The Platelet Count Can Predict In-hospital Death in HIV-negative Smear-positive Pulmonary Tuberculosis InpatientsHideto Goto, Nobuyuki Horita, Ken Tashiro, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2017
Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary TuberculosisToshinori Tsukahara, Nobuyuki Horita, Ken Tashiro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2023
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting StrategiesHibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, et al.
Communications Biology|April 4, 2024
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusionShunta Mori, Hiroki Izumi, Mitsugu Araki, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2023
Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia studyYutaro Tamiya, Shingo Matsumoto, Yoshitaka Zenke, et al.
Cancer Science|June 2, 2023
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinomaYosuke Kagawa, Tokiko Nakai, Tetsuro Taki, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinomaYutaro Tamiya, Tokiko Nakai, Ayako Suzuki, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2023
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinomaYu Tanaka, Tokiko Nakai, Ayako Suzuki, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Cancer Research|July 11, 2021
Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung CancerYukie Kashima, Daisuke Shibahara, Ayako Suzuki, et al.
Scientific Reports|April 14, 2017
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatientsKen Tashiro, Nobuyuki Horita, Kenjiro Nagai, et al.
Internal Medicine (Tokyo, Japan)|January 12, 2018
The Platelet Count Can Predict In-hospital Death in HIV-negative Smear-positive Pulmonary Tuberculosis InpatientsHideto Goto, Nobuyuki Horita, Ken Tashiro, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2017
Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary TuberculosisToshinori Tsukahara, Nobuyuki Horita, Ken Tashiro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2023
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting StrategiesHibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, et al.
Communications Biology|April 4, 2024
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusionShunta Mori, Hiroki Izumi, Mitsugu Araki, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2023
Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia studyYutaro Tamiya, Shingo Matsumoto, Yoshitaka Zenke, et al.
Cancer Science|June 2, 2023
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinomaYosuke Kagawa, Tokiko Nakai, Tetsuro Taki, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinomaYutaro Tamiya, Tokiko Nakai, Ayako Suzuki, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2023
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinomaYu Tanaka, Tokiko Nakai, Ayako Suzuki, et al.
Pageof 6